Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is a globally renowned leader in scientific services, headquartered in Waltham, Massachusetts, providing a vast portfolio of laboratory equipment, reagents, and innovative software solutions to research and clinical laboratories worldwide. The company is considered one of the dominant players in the clinical trial supplies market, primarily operating through its subsidiary, Patheon, formerly known as Fisher Clinical Services. Thermo Fisher offers end-to-end global clinical supply chain management, leveraging an extensive, worldwide network of over 27 purpose-built GMP/GDP-compliant facilities and 40 partner depots across five continents. This massive infrastructure is critical for ensuring the compliant movement, management, and timely delivery of clinical supplies to more than 150 countries. Their comprehensive services include clinical manufacturing for small and large molecules, as well as advanced therapies, and a full range of logistics and supply chain services. Key offerings include strategic comparator drug sourcing utilizing proprietary data-driven insights for cost savings, advanced clinical packaging and labeling, and specialized cold chain logistics management. This robust, integrated approach supports diverse therapeutic areas and is essential for mitigating the risks associated with complex international clinical supply chains.
Latest Market Research Report on Clinical Trial Supplies Download PDF Brochure Now
Catalent
Catalent Inc., a multinational Contract Development & Manufacturing Organization (CDMO) headquartered in Somerset, New Jersey, is a leading strategic partner to the pharmaceutical industry. While operating as a public company, its market presence in clinical trial supplies is also supported by Novo Holdings A/S (Denmark), a leading player in this sector. Catalent specializes in advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapy, and consumer health products. The company is a major provider of clinical trial supplies, offering solutions integrated across the entire pharmaceutical lifecycle. Their clinical supply services are delivered through a strategic network of core facilities spanning the US, EU, and Asia/Pacific, complemented by a global network of over 50 depots on six continents, ensuring efficient management and global distribution of investigational products. Services include comprehensive clinical packaging and labeling, rigorous analytical testing, and global logistics. Catalent is known for its ongoing investment in expanding its infrastructure, such as the Schorndorf, Germany facility, to meet the rising global demand for highly efficient and reliable management of clinical trial materials, accelerating the journey of new treatments to patients worldwide.
Almac Group
Almac Group is an established, privately-owned Contract Development & Manufacturing Organization (CDMO) based in Northern Ireland, providing an extensive and integrated range of services across the pharmaceutical and biotech development lifecycle. Almac is recognized as a top-tier global provider of clinical supply solutions, offering a complete and agile suite of services built on robust processes and cutting-edge technology. Their specialized Clinical Services division provides comprehensive support throughout the clinical trial process. Almac’s core contributions to clinical trial supplies include expert commercial drug procurement and sourcing for all global markets, advanced packaging and labeling solutions that meet stringent regulatory standards, global distribution capabilities, and Qualified Person (QP) services for drug release in Europe. As one of the longest-established global providers, Almac is committed to the reliable delivery of responsive and future-proof operations. The company’s ability to integrate clinical supply services with its broader expertise in API manufacture, formulation development, and analytical services reinforces its reputation as a strategic partner for advancing products from research through to commercialization.
Parexel International
Parexel International is a global biopharmaceutical services provider, recognized as one of the largest Contract Research Organizations (CROs) in the world, with headquarters in the US. Founded in 1982, Parexel specializes in clinical research, regulatory consulting, and market access, supporting pharmaceutical and biotechnology companies globally. Parexel’s involvement in the clinical trial supplies sector centers on providing comprehensive clinical trial supply and logistics services, which are critical for navigating the complexities of global studies. They develop and execute full supply chain management strategies, ensuring the timely and safe delivery of investigational products (IPs) and necessary ancillary supplies to sites across the world. As a major CRO, Parexel seamlessly integrates clinical supply management into its full range of Phase I to Phase IV clinical development services. This strategic integration, supported by a global team, is essential for accelerating the drug development timeline and ensuring that patient recruitment, site selection, and product delivery are aligned for efficient trial execution and improved patient health outcomes worldwide.
IQVIA
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences industry. As one of the largest Contract Research Organizations (CROs), IQVIA leverages deep industry knowledge and proprietary data assets. IQVIA’s Clinical Trial Supplies solution is an end-to-end service designed to manage investigational products (IPs), comparator drugs, and ancillaries efficiently. The company excels at mitigating risks within complex global supply chains through its Clinical Supply Chain Management team, which strategizes and oversees all required activities. A distinctive component of their offering is a unique comparator drug sourcing solution that drives significant cost savings by utilizing proprietary global drug pricing databases and data-driven insights. Furthermore, IQVIA integrates its industry-leading randomization and trial supply management (RTSM) business, Cenduit, which employs advanced forecasting and automated supply optimization tools. By working closely with a strong network of vendor partners for packaging, labeling, and distribution, IQVIA acts as an integral, technology-enabled partner in the planning and seamless implementation of global clinical trials.
Piramal Pharma Solutions
Piramal Pharma Solutions (PPS), part of the Piramal Group and headquartered in Mumbai, India, is a leading Contract Development and Manufacturing Organization (CDMO). The company offers integrated, end-to-end services across the entire pharmaceutical lifecycle, from early development through commercialization. Piramal Pharma Solutions is a recognized provider in the clinical trial supplies market, with services focused on ensuring the efficient and compliant supply of investigational materials. Their value proposition stems from integrating clinical supply support directly with development and manufacturing expertise. PPS provides comprehensive support for clinical programs, including the manufacturing of Active Pharmaceutical Ingredients (APIs) and finished drug products, along with full commercialization support. By offering a unified approach, Piramal helps its clients streamline the supply chain and maintain quality control. This allows for a smooth transition of therapeutic products through all clinical phases, ensuring that trials are consistently supported with the necessary quality and quantity of products up to final global market launch.
PCI Pharma Services
PCI Pharma Services is a strategic outsourcing partner to the global biopharmaceutical industry, providing integrated services focused on drug development and commercialization. The company’s mission is to minimize complexity and ensure product integrity throughout the entire global supply chain. PCI Pharma Services is a significant player in the clinical trial supply market, offering a comprehensive suite of clinical support services tailored for various stages of drug development. Their core clinical trial offerings include specialized, compliant packaging and labeling services for investigational products, often for complex materials like biologics, and utilizing technologies such as active-blister solutions. They also provide key services like aseptic fill/finish processing and analytical lab services to support the release of clinical materials. The company’s integrated approach spans clinical trial manufacturing, packaging, and logistics, enabling them to support clinical studies from early phase I trials through to final commercial supply, making the global supply process simpler for their biotech and pharmaceutical clients.
Sharp Clinical
Sharp Services, LLC. is a global leader in contract pharmaceutical packaging and specialized clinical supply chain services, with a history dating back to 1952. Sharp partners with biotechnology and pharmaceutical clients to support their products through the critical stages of development, from initial Phase I trials to commercial launch and ongoing lifecycle management. Sharp Clinical’s expertise is centered on delivering streamlined, compliant, and efficient supply chain and packaging support for global clinical studies. They offer comprehensive clinical supply chain management and specialized packaging and labeling services, with a strong focus on maintaining product quality and integrity while ensuring strict adherence to international regulatory requirements across diverse jurisdictions. By providing tailored support that addresses complex logistical and regulatory demands from the earliest stages, Sharp plays a vital role in de-risking the drug development process and enabling the seamless progression of drug candidates through clinical investigation to eventual market availability.
Marken (DHL Supply Chain)
Marken is a wholly-owned subsidiary of DHL Supply Chain, positioning it as a preeminent specialist logistics provider dedicated to the life sciences and healthcare sectors. Marken combines profound clinical supply expertise with the vast global logistics network of DHL, supporting the development and distribution of traditional and advanced therapies, including cell and gene therapies, across the world. Marken’s key contribution to the clinical trial supplies market is its specialization in complex, global clinical logistics. They manage the entire clinical supply chain, with an emphasis on high-value, temperature-sensitive materials, such as investigational medicinal products (IMPs), ancillary supplies, and biological samples. Utilizing DHL’s extensive reach, Marken ensures the regulatory-compliant, temperature-controlled, and timely delivery of clinical supplies directly to investigator sites and patients in over 220 countries. Their core services, including direct-to-patient logistics and cold chain management, are critical for executing decentralized and complex global clinical trials, underscoring their vital role in the logistical backbone of pharmaceutical development.
Biocair
Biocair International Ltd. is a provider of highly specialized logistics services, exclusively dedicated to the biotechnology, pharmaceutical, and life sciences sectors. The company is committed to delivering comprehensive and compliant global transportation and supply chain solutions tailored to the unique and often complex requirements of biological and pharmaceutical materials. Biocair’s expertise lies in offering specialized clinical trial logistics, which includes providing comprehensive shipping solutions globally while excelling in handling highly sensitive, temperature-controlled consignments, often referred to as cold chain logistics. They support cell and gene supply chain solutions, utilizing the latest monitoring technology to ensure product integrity. With a robust international presence, delivering services in over 124 countries, Biocair is a crucial partner for sponsors requiring secure, precise, and reliable international transport of clinical trial supplies. They provide end-to-end visibility for all consignments throughout the pharmaceutical shipping process, effectively mitigating the risks and complexities associated with international customs clearance and movement of essential clinical materials.
Latest Market Research Report on Clinical Trial Supplies Download PDF Brochure Now